The FDA advisory panel recommended last week that Truvada be approved for prevention of HIV[1]. Low molecular weight heparin (enoxaparin) has been approved for the "prevention of deep vein thrombosis" for years.[2]
In other words, the following:
> The only way that testing and approval can proceed is for it to be applicable to the treatment of a specific disease, and prevention doesn't count. (emphasis mine)
In other words, the following:
> The only way that testing and approval can proceed is for it to be applicable to the treatment of a specific disease, and prevention doesn't count. (emphasis mine)
... is not true.
[1] http://www.cbsnews.com/8301-504763_162-57432491-10391704/tru...
[2] http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/uc...